Form 4: CRA International Director Karen Keenan Receives Equity Grant

Sentiment:

Insider Transaction Report


CRA International, Inc. Director Karen C. Keenan was granted 696 shares of common stock, vesting over four years, aligning her interests with shareholders.

Summary

  • Karen C. Keenan, a Director of CRA International, Inc. (CRAI), acquired 696 shares of common stock.
  • The transaction occurred on July 17, 2025, with a reported price of $0 per share, indicating a stock grant.
  • These shares will vest in four equal annual installments, starting on the first anniversary of the grant date.
  • Following this transaction, Karen C. Keenan directly beneficially owns 2,400 shares of CRA International, Inc. common stock.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive as it reflects a standard practice of aligning director interests with shareholders through equity compensation, indicating stability in governance and compensation strategy.

Positives

  • The grant of shares to a director aligns management's interests with those of shareholders, promoting long-term value creation.
  • The vesting schedule encourages long-term commitment and retention of key board members.

Negatives

  • No specific negative points are indicated by this routine insider transaction.

Risks

  • No specific risks are detailed in this Form 4 filing beyond the general risks associated with equity compensation, such as stock price fluctuation impacting the value of the grant.

Future Outlook

The vesting schedule for the granted shares indicates a long-term incentive structure for the director, with shares vesting over four equal annual installments beginning on the first anniversary of the grant date.

Industry Context

This is a standard equity compensation practice for directors in publicly traded companies across various industries, designed to align their interests with long-term shareholder value.

Comparison to Industry Standards

  • Granting restricted stock or similar equity awards to directors is a common practice among U.S. public companies, including those in the consulting and professional services sector like CRA International.
  • The vesting schedule of four equal annual installments is a typical structure for long-term incentive plans, comparable to practices seen at firms such as FTI Consulting, Inc. (FCN) or Huron Consulting Group Inc. (HURN), which also utilize equity grants to compensate and retain their board members.
  • The $0 price indicates a grant, which is standard for equity compensation rather than a purchase, aligning with compensation models at peer professional services firms.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Director CompensationGrant of 696 shares of common stock to Director Karen C. Keenan as part of her compensation package.07/17/2025Aligns director's long-term interests with shareholder value through equity ownership and a multi-year vesting schedule.

Stakeholder Impact

  • Shareholders: The equity grant aligns the director's financial interests with long-term shareholder value creation.
  • Employees: While not directly impacting employees, it sets a precedent for executive and director compensation structures.

Next Steps

  • The granted shares will vest in four equal annual installments, beginning on July 17, 2026.

Key Dates

DateDescription
07/17/2025Date of stock grant transaction.
07/21/2025Date the Form 4 was filed.
07/17/2026First anniversary of grant date, when the first installment of shares begins to vest.

Keywords

CRA International, CRAI, SEC Form 4, Insider Transaction, Stock Grant, Equity Compensation, Director Compensation, Beneficial Ownership, Corporate Governance

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.